Enhance your practice with CME and tools that focus on the management of neurological conditions.
Uncovering TK2d: How to Navigate Diagnostic Challenges
Kaitlin Batley, MD
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Ethan Meltzer, MD
Navigating Emerging Biomarkers in MS Care
Exploring Genetic Links Between EBV Clearance and MS Risk
David Hafler, MD, FANA, MSc
Navigating Emerging Treatment Options in MG
Qihua Fan, MD
The New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
Discharge Planning After Myasthenic Crisis
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
Multiple dates & locations available
Navigating the Limitations of Current BD Therapies
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Recurrence as the Rule: BD Symptoms Persist and Cycle
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
The Role of B-Cell Depletion in MS Care
Precision Medicine for Myasthenia Gravis
New Therapies, New Strategy: Rethinking MG Inpatient Care
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Outcome Measures Capture Progression in Late-Onset TK2d
More Than a Myopathy: The Lived Experience of TK2d
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.